The First Human Reprogramming Trial Is an Eye Study—Not Proof of Age Reversal
ER-100 has entered an 18-person Phase 1 eye trial. Here is what partial epigenetic reprogramming has—and has not—shown in humans.
The Daily Rounds: Longevity & Health Care Brief | June 14, 2026
🧠 Brain Plasticity Has No Age Ceiling — A 4,000-person, three-year UT Dallas study confirms cognitive performance can improve well into the 90s, making brain health a genuinely actionable target at every life stage. 🧠 Blood Cancer Mutations May Be a Missing Alzheimer's Mechanism — TET2, DNMT3A, and ASXL1 mutations in brain microglia create a destructive inflammatory environment in Alzheimer's tissue, opening a new door to both screening and repurposed cancer therapies. 🤖 A Vaccine Designed to End the Fentanyl Crisis — Scripps Research's cross-reactive fentanyl antibody platform blocks the drug before it reaches the brain and extends protection to designer analogs, with human trials already underway in 2026. 💪 GLP-1 Drugs Are Reducing Physical Activity, Not Increasing It — Fitbit data from ENDO 2026 shows step counts falling after GLP-1 initiation, making exercise counseling a critical and often missing element of metabolic treatment plans. 🥗 GLP-1 Drugs May Also Be Breast Cancer Prevention Tools — A 110,000-woman Penn Medicine cohort study found 30% lower breast cancer incidence in GLP-1 users, with a multisite prevention trial now being planned.
The Strength Training Sweet Spot: 30 Years of Data From 147,000 People Reveals the Exact Weekly Dose That Lowers Mortality Risk
A landmark British Journal of Sports Medicine analysis tracked 147,374 adults across three Harvard cohort studies for up to 30 years and found that 90 to 120 minutes of weekly…
Your Light Diet: How Bright Days and Dark Nights Shape Your Healthspan
A landmark UK Biobank study of 13 million hours of wrist-sensor data found that bright days and dark nights predict longer life. Here is the science of circadian light, and…
Sleep Regularity Beats Sleep Duration: The Overlooked Fundamental That Predicts How Long You Live
A wave of accelerometer studies in more than 130,000 adults shows that when you sleep matters more than how long. Inside the Sleep Regularity Index, the mortality and cardiovascular data,…
The NAD+ Decline: Inside the Cellular Energy Crisis of Aging and What the 2026 Trials Actually Show
NAD+, the coenzyme that powers every cell, falls steadily as we age. Inside the biology of the decline, the CD38 and mitochondrial mechanisms driving it, what the NMN and nicotinamide…
No Drug Has Ever Reversed Cartilage Loss. Stanford May Have Just Changed That.
A Stanford Medicine study published June 12 in Science found that blocking an aging protein called 15-PGDH regrew knee cartilage in old mice, prevented arthritis after ACL-type injuries, and triggered…
The Zone 2 Reckoning: What the 2025 Evidence Really Says About Slow Cardio and Longevity
For three years Zone 2 has been sold as the optimal longevity cardio. A July 2025 Sports Medicine review pushed back. Inside what the evidence actually shows about slow cardio,…
The Gut Molecule That Sabotages Your Metabolism: Inside Imidazole Propionate and the 2025 Atherosclerosis Breakthrough
A gut bacterial metabolite called imidazole propionate has gone from obscure molecule to validated driver of insulin resistance, type 2 diabetes, heart failure, and atherosclerosis. Inside the University of Gothenburg…
The Daily Rounds: Longevity & Health Care Brief | June 10, 2026
🧠 Ultra-Processed Foods Steal Your Focus: Even among healthy eaters, each 10% increase in ultra-processed food intake measurably impairs attention in a 2,100-person study. 🔬 A Single Gene Proves Evolution's Aging Trade-Off: Hebrew University's CRISPR study of vgll3 provides the first vertebrate experimental proof that fast early growth directly accelerates aging and cancer risk. ❤️ Finerenone Expands Protection to Millions More Patients: Three ERA Congress 2026 trials show the drug delivers significant heart and kidney protection to non-diabetic CKD patients with previously limited options. 🧠 ETH Zurich Discovers New Alzheimer's Mechanism: Compound 10 blocks a newly identified GRK2 aggregation process that damages mitochondria and promotes amyloid formation in brain cells. 🥗 Vegetable Nitrates Deliver Targeted Heart Protection: Source matters; vegetable-derived nitrates cut cardiovascular disease risk 15% in 54,000 adults while processed meat nitrates show no comparable benefit.
